증례 : 지질강하제에 의한 횡문근 융해증 1예 ( A Case of Rhabdomyolysis Induced by Lipid Lowering Agent ) () |
Author |
고은미(Eun Mi Koh),이태원(Tae Won Lee),임천규(Chun Gyoo Ihm),김광원(Kwang Won Kim),김명재(Myung Jae Kim),최영길(Young Kil Choi), |
|
Affiliation |
|
Abstract |
Bezafibrate is a lipid-lowering agent and one of the
fibric acid derivatives. It is relatively safe and well
tolerated and adverse reactions to bezafibrate have
largely been restricted to gastrointestinal
distrubances. But a few cases of rhabdomyolysis after
bezafibrate administration have been reported and
recently we experienced bezafibrate-induced
rhabdomyolysis in patients with chronic renal failure.
So we report this case with the bone scan finding and
the literature review. We believe that this is the
first case report of bezafibrate-induced rhabdomyolysis
in Korea. AB: Bezafibrate is a lipid-lowering agent and
one of the fibric acid derivatives. It is relatively
safe and well tolerated and adverse reactions to
bezafibrate have largely been restricted to
gastrointestinal distrubances. But a few cases of
rhabdomyolysis after bezafibrate administration have
been reported and recently we experienced bezafibrate-
induced rhabdomyolysis in patients with chronic renal
failure. So we report this case with the bone scan
finding and the literature review. We believe that this
is the first case report of bezafibrate-induced
rhabdomyolysis in Korea. AB: Bezafibrate is a lipid-
lowering agent and one of the fibric acid derivatives.
It is relatively safe and well tolerated and adverse
reactions to bezafibrate have largely been restricted
to gastrointestinal distrubances. But a few cases of
rhabdomyolysis after bezafibrate administration have
been reported and recently we experienced bezafibrate-
induced rhabdomyolysis in patients with chronic renal
failure. So we report this case with the bone scan
finding and the literature review. We believe that this
is the first case report of bezafibrate-induced
rhabdomyolysis in Korea. |
Keyword |
|
Full text Article |
28500978.pdf
|
|
|